Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?

被引:14
作者
Polasik, Arkadius [1 ]
Tzschaschel, Marie [1 ]
Schochter, Fabienne [1 ]
de Gregorio, Amelie [1 ]
Friedl, Thomas W. P. [1 ]
Rack, Brigitte [1 ]
Hartkopf, Andreas [2 ]
Fasching, Peter A. [3 ]
Schneeweiss, Andreas [4 ]
Mueller, Volkmar [5 ]
Huober, Jens [1 ]
Janni, Wolfgang [1 ]
Fehm, Tanja [6 ]
机构
[1] Univ Klinikum Ulm, Klin Gynakol & Geburtshilfe, Ulm, Germany
[2] Univ Klinikum Tubingen, Klin Gynakol & Geburtshilfe, Tubingen, Germany
[3] Univ Klinikum Erlangen, Klin Gynakol & Geburtshilfe, Erlangen, Germany
[4] Univ Klinikum Heidelberg, Natl Ctr Tumorerkrankungen, Heidelberg, Germany
[5] Univ Klinikum Hamburg Eppendorf, Klin Gynakol & Geburtshilfe, Hamburg, Germany
[6] Heinrich Heine Univ Dusseldorf, Klin Gynakol & Geburtshilfe, Dusseldorf, Germany
关键词
breast; Her-2/neu (human epidermal growth factor recptor); hormonal receptor; mammary gland tumor; metastasis; POOLED ANALYSIS; HER2; STATUS; ESTROGEN-RECEPTOR; PIK3CA MUTATIONS; ESR1; MUTATIONS; BONE-MARROW; RESISTANCE; DISEASE; MARKER; SITES;
D O I
10.1055/s-0043-122884
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Dissemination of tumour cells and the development of solid metastases occurs via blood vessels and lymphatics. Circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) can be detected in venous blood in patients with early and metastatic breast cancer, and their prognostic relevance has been demonstrated on numerous occasions. Repeated testing for CTCs and ctDNA, or regular so-called "liquid biopsy", can be performed easily at any stage during the course of disease. Additional molecular analysis allows definition of tumour characteristics and heterogeneity that may be associated with treatment resistance. This in turn makes personalised, targeted treatments possible that may achieve both improved overall survival and quality of life.
引用
收藏
页码:1291 / 1298
页数:8
相关论文
共 46 条
[1]  
[Anonymous], 2017, AKTUELLE EMPFEHLUNGE
[2]  
Baselga J, SAN ANT BREAST CANC
[3]   Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies [J].
Bettegowda, Chetan ;
Sausen, Mark ;
Leary, Rebecca J. ;
Kinde, Isaac ;
Wang, Yuxuan ;
Agrawal, Nishant ;
Bartlett, Bjarne R. ;
Wang, Hao ;
Luber, Brandon ;
Alani, Rhoda M. ;
Antonarakis, Emmanuel S. ;
Azad, Nilofer S. ;
Bardelli, Alberto ;
Brem, Henry ;
Cameron, John L. ;
Lee, Clarence C. ;
Fecher, Leslie A. ;
Gallia, Gary L. ;
Gibbs, Peter ;
Le, Dung ;
Giuntoli, Robert L. ;
Goggins, Michael ;
Hogarty, Michael D. ;
Holdhoff, Matthias ;
Hong, Seung-Mo ;
Jiao, Yuchen ;
Juhl, Hartmut H. ;
Kim, Jenny J. ;
Siravegna, Giulia ;
Laheru, Daniel A. ;
Lauricella, Calogero ;
Lim, Michael ;
Lipson, Evan J. ;
Marie, Suely Kazue Nagahashi ;
Netto, George J. ;
Oliner, Kelly S. ;
Olivi, Alessandro ;
Olsson, Louise ;
Riggins, Gregory J. ;
Sartore-Bianchi, Andrea ;
Schmidt, Kerstin ;
Shih, Ie-Ming ;
Oba-Shinjo, Sueli Mieko ;
Siena, Salvatore ;
Theodorescu, Dan ;
Tie, Jeanne ;
Harkins, Timothy T. ;
Veronese, Silvio ;
Wang, Tian-Li ;
Weingart, Jon D. .
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)
[4]   Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data [J].
Bidard, Francois-Clement ;
Peeters, Dieter J. ;
Fehm, Tanja ;
Nole, Franco ;
Gisbert-Criado, Rafael ;
Mavroudis, Dimitrios ;
Grisanti, Salvatore ;
Generali, Daniele ;
Garcia-Saenz, Jose A. ;
Stebbing, Justin ;
Caldas, Carlos ;
Gazzaniga, Paola ;
Manso, Luis ;
Zamarchi, Rita ;
Fernandez de Lascoiti, Angela ;
De Mattos-Arruda, Leticia ;
Ignatiadis, Michail ;
Lebofsky, Ronald ;
van Laere, Steven J. ;
Meier-Stiegen, Franziska ;
Sandri, Maria-Teresa ;
Vidal-Martinez, Jose ;
Politaki, Eleni ;
Consoli, Francesca ;
Bottini, Alberto ;
Diaz-Rubio, Eduardo ;
Krell, Jonathan ;
Dawson, Sarah-Jane ;
Raimondi, Cristina ;
Rutten, Annemie ;
Janni, Wolfgang ;
Munzone, Elisabetta ;
Caranana, Vicente ;
Agelaki, Sofi A. ;
Almici, Camillo ;
Dirix, Luc ;
Solomayer, Erich-Franz ;
Zorzino, Laura ;
Johannes, Helene ;
Reis-Filho, Jorge S. ;
Pantel, Klaus ;
Pierga, Jean-Yves ;
Michiels, Stefan .
LANCET ONCOLOGY, 2014, 15 (04) :406-414
[5]   Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer [J].
Board, Ruth E. ;
Wardley, Andrew M. ;
Dixon, J. Michael ;
Armstrong, Anne C. ;
Howell, Sacha ;
Renshaw, Lorna ;
Donald, Emma ;
Greystoke, Alastair ;
Ranson, Malcolm ;
Hughes, Andrew ;
Dive, Caroline .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (02) :461-467
[6]   A pooled analysis of bone marrow micrometastasis in breast cancer [J].
Braun, S ;
Vogl, FD ;
Naume, B ;
Janni, W ;
Osborne, MP ;
Coombes, RC ;
Schlimok, G ;
Diel, IJ ;
Gerber, B ;
Gebauer, G ;
Pierga, JY ;
Marth, C ;
Oruzio, D ;
Wiedswang, G ;
Solomayer, EF ;
Kundt, G ;
Strobl, B ;
Fehm, T ;
Wong, GYC ;
Bliss, J ;
Vincent-Salomon, A ;
Pantel, K .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (08) :793-802
[7]   Circulating Tumor Nucleic Acids: Perspective in Breast Cancer [J].
Casciano, Ida ;
Di Vinci, Angela ;
Banelli, Barbara ;
Brigati, Claudio ;
Forlani, Alessandra ;
Allemanni, Giorgio ;
Romani, Massimo .
BREAST CARE, 2010, 5 (02) :75-80
[8]   Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer A Secondary Analysis of the BOLERO-2 Clinical Trial [J].
Chandarlapaty, Sarat ;
Chen, David ;
He, Wei ;
Sung, Patricia ;
Samoila, Aliaksandra ;
You, Daoqi ;
Bhatt, Trusha ;
Patel, Parul ;
Voi, Maurizio ;
Gnant, Michael ;
Hortobagyi, Gabriel ;
Baselga, Jose ;
Moynahan, Mary Ellen .
JAMA ONCOLOGY, 2016, 2 (10) :1310-1315
[9]   Circulating Tumor DNA to Monitor Metastatic Breast Cancer REPLY [J].
Dawson, Sarah-Jane ;
Rosenfeld, Nitzan ;
Caldas, Carlos .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (01) :93-94
[10]  
Di Leo A, SAN ANT BREAST CANC